Beta HCG Antibody is a highly specific and sensitive monoclonal or polyclonal antibody designed to detect the beta subunit of human chorionic gonadotropin (HCG). It plays a critical role in diagnostic and research applications, particularly in the detection of pregnancy and monitoring certain types of cancers, including trophoblastic tumors and germ cell tumors. This antibody is widely utilized in immunoassays and other in vitro diagnostic (IVD) platforms due to its precision and reliability.

Diagnostic Testing:
Essential for rapid diagnostic tests, ELISA, and immunoassays used in pregnancy detection. Facilitates the identification and monitoring of HCG-secreting tumors, including testicular and ovarian cancers.

Research & Development:
Widely employed in studying HCG-related biological processes, including fetal development and tumor progression. Supports the development of new diagnostic tools and therapeutic interventions targeting HCG.

IVD Manufacturing:
Integral in producing high-performance diagnostic kits for the detection of beta HCG in clinical samples. Provides consistent and accurate results, ensuring reliability across diverse assay systems.